The Office of Developmental Programs (ODP) has shared ODPANN 24-014. The purpose of this announcement is to communicate that Temple University Harrisburg Certified Investigator Program and ODP will be facilitating Forums for Certified Investigators (CI) and others involved in the incident investigation process. This also announces the posting of Q&A documents from past CI Forums on myODP. Please view the announcement for information and details.
The Office of Developmental Programs (ODP) has shared this important announcement from the U.S. Food and Drug Administration (FDA) about a recall of two cough medicine products by Robitussin. The products are Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult. Please see the specific Lot Numbers below that are involved in the recall. If you have one of these products with the matching Lot Number, stop use immediately and contact your health care provider.
Haleon Issues Voluntary Nationwide Recall of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult Products Due to Microbial Contamination
Summary
Company Announcement Date: January 24, 2024
FDA Publish Date: January 24, 2024
Product Type: Drugs
Reason for Announcement: Microbial Contamination
Company Name: Haleon
Brand Name: Robitussin
Product Description: Cough syrups
Haleon is voluntarily recalling eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult to the consumer level. The product is being recalled due to microbial contamination.
In immunocompromised individuals, the use of the affected product could potentially result in severe or life-threatening adverse events, such as fungemia or disseminated fungal infection. In non-immunocompromised consumers, the population most likely to use the product, life-threatening infections are not likely to occur. However, the occurrence of an infection that may necessitate medical intervention cannot be completely ruled out. To date, Haleon has not received any reports of adverse events related to this recall.
Robitussin Honey CF Max Day and Nighttime are cough syrups indicated for the temporary relief of symptoms occurring with cold or flu, hay fever, or other respiratory allergies. This recall covers only the following lots:
| Product | Lot Number | Expiry Date |
| ROBITUSSIN HONEY CF MAX DAY ADULT 4OZ |
T10810 | 31OCT2025 |
| ROBITUSSIN HONEY CF MAX DAY ADULT 8OZ |
T08730 T08731 T08732 T08733 T10808 |
31MAY2025 31MAY2025 31MAY2025 31MAY2025 30SEP2025 |
| ROBITUSSIN HONEY CF MAX NT ADULT 8OZ |
T08740 T08742 | 30JUN2026 30JUN2026 |
Haleon is notifying its distributors and customers directly and has provided them with instructions for the return of all recalled products. Consumers that have purchased the product listed should stop consumption immediately. Please call our Consumer Relations team at +1-800-245-1040 (Monday through Friday 8:00 am – 6:00 pm Eastern Time) or reach out via email.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail, or by fax.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
The Office of Developmental Programs (ODP) has released ODPANN 24-013. This announcement shares details regarding the registration for six half-day virtual training sessions focused on ODP’s expectations of Residential Provider Program Specialists in the implementation of the Residential ISP Staffing approach. Please view the announcement for information and details.
February continues the series on Participant Directed Services. Creating an Everyday Life using Waiver Services comes with some exciting opportunities and challenges. Many individuals use Participant Directed Services to pursue their vision and create the life they want. Please join the PA Family Network (PAFN) as they explore more about Participant Direction and offer resources and information. These workshops are created by family members and self-advocates FOR family members and self-advocates.
Register here for upcoming events.
Support Groups
LifeCourse Workshops
Waiver Workshops
Community Engagement Workshops:
There will be an afternoon and evening session each day.
Join us for our Participation Direction Summits this spring!
Visit the PA Family Network website for more information about our summit sessions, lunch, and dinner!
The Office of Developmental Programs (ODP) has shared ODPANN 24-011. This announcement is to notify that an updated Trainer Manual and Presentation Slides are now available in the Trainer Resources section of the Medication Administration system. These resources provide instruction for trainers on how to grade Observation Checks in the Online Student courses as well as advertise two new face-to-face classes as part of the winter 2024 Train-the-Trainer Q1 2024 Face-to-Face Schedule. Please view the announcement for information and details.
The Office of Developmental Programs (ODP) has shared ODPANN 24-010. The purpose of this communication is to announce the posting of a recording of the webinar Residential Individual Support Plan (ISP): It’s About the Person, Not the Numbers. Please view the announcement for information and details.
The Office of Developmental Programs (ODP) has shared ODPANN 24-009. The purpose of this communication is to announce that registration is open for the next Virtual Office Hours (VOH) with ODP’s Policy Department. This session is on Navigating ODP Resources and is geared towards individuals and families who are just beginning to learn about ODP or for those who want a basic understanding of the topic being discussed. Please view the announcement for registration information and details.
Prev